CRISPR Therapeutics AG

XNAS: CRSP

Momentum Trap

Download real time

37.22 -0.37 (-0.98%)

45.17% Fall from 52W High

2.0M XNAS Volume

XNAS 13 May, 2025 5:30 PM (EDT)

3,214.5

Market Cap

High in industry

0.1

Beta 1Year

Very Low volatility

CRISPR Therapeutics AG - CRSP - stock price prediction, stock price target, analyst ratings from 28 analysts

CRISPR Therapeutics AG has a share price target of US$ 82, revenue growth forecast of 39.0%, and profit growth estimate of -26.6% for FY25, based on top 28 analyst calls.

Forecaster Screeners